Positive Trial of Methotrexate in Hand OA Has Modest Results

A randomized controlled trial of methotrexate in inflammatory hand OA demonstrated clinical benefit, suggesting a potential role for immunosuppression in a subset of patients with an inflammatory OA phenotype.

Related Keywords

Norway ,Melbourne ,Victoria ,Australia ,Monash ,South Australia ,Oslo ,Michigan ,United States ,Amandae Nelson ,Flavia Cicuttini ,Idak Haugen ,Musculoskeletal Unit At Monash University ,National Health ,Health Assessment Questionnaire ,Diakonhjemmet Hospital Center ,American College Of Rheumatology ,Research Council Of Australia ,Treat Hand Osteoarthritis ,Musculoskeletal Unit ,Monash University ,Alfred Hospital ,American College ,Australian Canadian ,Functional Index ,Hand Osteoarthritis ,Michigan Hand Outcomes Questionnaire ,North Carolina ,Chapel Hill ,Thurston Arthritis Research Center ,Diakonhjemmet Hospital ,Musculoskeletal Diseases ,Medscape Medical ,Medical Research Council ,Osteoarthritis Oa ,Steoarthritis Generalized ,A Osteoarthritis ,Egenerative Joint Disease Djd ,Rthritis Degenerative ,Eneralized Osteoarthritis ,Degenerative Arthritis ,Hands ,Disease Modifying Antirheumatic Drugs Dmards ,Mard Disease Modifying Antirheumatic Drug ,Hands Osteoarthritis ,Pain Management ,Spain ,Rheumatoid Arthritis ,A ,Arthritis ,Oint Inflammati ,